THERAPEUTICS ACQUISITION
Therapeutics Acquisition operates as a blank check company. It aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
THERAPEUTICS ACQUISITION
Industry:
Business Development Finance Financial Services
Address:
Boston, Massachusetts, United States
Country:
United States
Total Employee:
1+
Status:
Active
Similar Organizations
FinServ Acquisition
FinServ Acquisition is a blank check company.
Industrial Tech Acquisitions
Industrial Tech Acquisitions operates as a blank check company.
Pershing Square Tontine Holdings
Pershing Square Tontine Holdings operates as a blank check company.
Stock Details
More informations about "Therapeutics Acquisition"
2024 Pharmaceutical Industry Mergers & Acquisitions Roundup
Jan 31, 2024 Eliem Therapeutics—Tenet Medicines. Eliem Therapeutics Inc. and Tenet Medicines Inc., a development-stage private biotechnology company, have entered into a definitive acquisition agreement whereby Eliem has agreed to acquire Tenet. Date of …See details»
Vividion Therapeutics Acquires Tavros Therapeutics to Expand
6 days ago San Diego, CA, USA, Berlin, Germany and Durham, NC, USA, January 8, 2025 Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing novel …See details»
Kyowa Kirin successfully completes acquisition ... - Orchard …
Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases. January 24, 2024 at 5:00 AM EST. ... In the new organizational …See details»
Agilent to Acquire North American CDMO BIOVECTRA
Jul 22, 2024 Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and …See details»
Kyowa Kirin Successfully Completes Acquisition of Orchard …
Jan 24, 2024 The acquisition of all outstanding shares of Orchard Therapeutics by way of a Scheme of Arrangement procedure under the UK Companies Act 2006 was completed on …See details»
Ratio Announces Expansion of Manufacturing Agreement with …
Mar 12, 2024 Ratio Therapeutics Inc. (Ratio), an emerging pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment …See details»
Bio/Pharma’s Top Mergers & Acquisitions Thus Far in …
Aug 1, 2024 AbbVie’s $8.7-billion acquisition of Cerevel Therapeutics. This week (August 1, 2024), AbbVie completed a key deal to boost its position in neuroscience-based drugs with its $8.7-billion acquisition of Cerevel …See details»
Novartis completes acquisition of Chinook Therapeutics
Basel, August 11, 2023 — Novartis today announced that it has completed its acquisition of Chinook Therapeutics, Inc., a Seattle, WA, based biopharmaceutical company focused on the …See details»
List of top Therapeutics Acquired Companies - Crunchbase
Feb 4, 2005 This list of companies and startups in the therapeutics space that have been acquired provides data on their funding history, investment activities, and acquisition trends. …See details»
Flamingo Therapeutics and Dynacure Announce …
Mar 2, 2023 Leuven (Belgium), Strasbourg (France), Philadelphia (USA)- March 2, 2023 /PRNewswire/-- Flamingo Therapeutics (“Flamingo”) and Dynacure, announced today that the companies have signed a definitive merger …See details»
Biogen proposes acquisition of partner Sage Therapeutics
5 hours ago Biogen has made an unsolicited offer to acquire its partner Sage Therapeutics following a year of significant challenges for the latter. The deal, which values Sage at $7.22 …See details»
Among 2024’s modest M&A action, cancer, immunology and …
Nov 7, 2024 As 2024 reaches its final months, deals like Pfizer’s $43 billion purchase of antibody-drug conjugate maker Seagen last year or Amgen’s $27.8 billion acquisition of rare …See details»
Roche inks $1.5B Poseida buyout to land off-the-shelf CAR-Ts
Nov 26, 2024 Roche has struck a $1.5 billion deal to buy Poseida Therapeutics. The takeover will establish off-the-shelf cell therapies, which Roche has said can democratize CAR-Ts, as a …See details»
Johnson & Johnson Strengthens Neuroscience Leadership with …
11 hours ago Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also …See details»
Novartis buys Chinook for $3.5 billion in race to treat rare kidney ...
Jun 12, 2023 Novartis said it has agreed to acquire U.S. biotech firm Chinook Therapeutics for up to $3.5 billion to boost its late-stage drug development line-up, raising the stakes in the …See details»
Johnson & Johnson Strengthens Neuroscience Leadership with …
1 day ago The acquisition also includes ITI-1284, a promising Phase 2 compound being studied in generalized anxiety disorder (GAD) and Alzheimer’s disease-related psychosis and …See details»
Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a …
Oct 19, 2021 Treadwell Therapeutics today announced the acquisition of TCRyption Inc., a company focusing on novel approaches to TCR based T cell therapy and a TIO Bioventures …See details»
FTC’s watchdog role in pharma mergers: Road bumps and the way …
AbbVie announced the conclusion of the acquisition on August 1, 2024, without more remarks regarding the probe. Conversely, the simultaneous transaction concerning BMS’ US$14 billion …See details»
Kyowa Kirin successfully completes acquisition of Orchard …
Therapeutics. The acquisition of all outstanding shares of Orchard Therapeutics by way of a Scheme of Arrangement procedure under the UK Companies Act 2006 was completed on ...See details»
Sage Therapeutics Confirms Receipt of Unsolicited Nonbinding ...
3 days ago Sage Therapeutics (Nasdaq: SAGE) is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every …See details»